Fulton Breakefield Broenniman’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.8M Buy
134,439
+13,047
+11% +$272K 0.17% 69
2026
Q1
$2.54M Buy
121,392
+12,763
+12% +$270K 0.17% 72
2025
Q4
$2.3M Buy
108,629
+5,361
+5% +$114K 0.15% 71
2025
Q3
$2.19M Buy
103,268
+7,453
+8% +$157K 0.14% 72
2025
Q2
$2.02M Buy
95,815
+62,336
+186% +$1.29M 0.14% 73
2025
Q1
$695K Buy
33,479
+13,818
+70% +$284K 0.05% 95
2024
Q4
$400K Buy
19,661
+8,716
+80% +$180K 0.03% 132
2024
Q3
$232K Buy
+10,945
New +$228K 0.02% 167

Other funds holding IBDW

Fulton Breakefield Broenniman's IBDW Position: Q2 2026 in Review

Fulton Breakefield Broenniman increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 11% in Q2 2026, buying an estimated $272K and bringing the position to 134,439 shares worth $2.8M. The position accounts for 0.17% of the portfolio, ranked #69.

Fulton Breakefield Broenniman first reported a position in IBDW in Q3 2024 and has held it in 8 quarters since. 290 funds tracked by Wall St. Rank hold IBDW as of Q2 2026.

  • Fulton Breakefield Broenniman held 134,439 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $2.8M as of Q2 2026.
  • Fulton Breakefield Broenniman bought 13,047 iShares iBonds Dec 2031 Term Corporate ETF shares in Q2 2026, an estimated $272K.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.17% of Fulton Breakefield Broenniman's portfolio in Q2 2026, its #69 holding.
  • Fulton Breakefield Broenniman first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q3 2024 and has held it in 8 quarters since.
  • 290 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q2 2026.

Based on Fulton Breakefield Broenniman's 13F filing for Q2 2026, filed 3 Aug 2026.